Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Mexico Stocks: Banregio, Genomma Lab, Penoles Shares Are Active

April 2 (Bloomberg) -- The following companies had unusual price changes in Mexico trading. Stock symbols are in parentheses, and prices are as of the close of trading.

The IPC index rose 1 percent to 39,908.54.

Genomma Lab Internacional SAB (LABB MM), the Mexican producer of over-the-counter drugs, climbed 0.8 percent to 23.51 pesos as UBS AG reiterated its buy recommendation. A research note dated today from Marimar Torreblanca, an analyst in Mexico City, said it “is trading at a very attractive level,” whether or not Prestige Brands Holdings Inc. accepts Genomma’s unsolicited bid.

Banregio Grupo Financiero SAB (GFREGIO MM), the Mexican bank that held an initial public offering last year, climbed 1.7 percent to 35.50 pesos. Citigroup Inc.’s Banamex unit reiterated its buy recommendation on Banregio, saying it’s among the “best positioned” banks to benefit from an increase in credit to small and medium-sized businesses.

Industrias Penoles SAB (PE&OLES* MM), Mexico’s largest silver producer and a miner of gold, climbed 2.9 percent to 638.21 pesos. Gold advanced after economic reports signaled improving demand in China and the U.S. Silver also climbed.

To contact the reporter on this story: Jonathan J. Levin in Mexico City at jlevin20@bloomberg.net

To contact the editor responsible for this story: David Papadopoulos at papadopoulos@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.